STOCK TITAN

INSM (NASDAQ: INSM) insider plans new Form 144 sale after recent trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock in a NASDAQ‑listed company has filed a Form 144 notice to sell 869 shares through Merrill Lynch, with an aggregate market value of $132,462. The filing states that 213,273,469 shares of this class were outstanding and lists an approximate sale date of February 5, 2026.

The securities to be sold were acquired on February 1, 2026 via stock plan activity from the issuer. The person filing, identified in recent sales as Martina Flammer, also sold multiple blocks of common shares between November 11, 2025 and February 3, 2026, with individual trades ranging from hundreds to tens of thousands of shares.

Positive

  • None.

Negative

  • None.

Insights

Form 144 shows ongoing insider share sales but at a modest scale.

This Form 144 indicates that a shareholder intends to sell 869 common shares with an aggregate market value of $132,462. The shares were recently acquired through stock plan activity on February 1, 2026, suggesting routine equity compensation usage rather than a large standalone divestment.

The notice also lists prior sales by Martina Flammer from November 11, 2025 through February 3, 2026, including blocks such as 31,226 shares and 12,303 shares. While these represent meaningful personal transactions, the filing shows 213,273,469 shares outstanding, which implies these trades are small relative to the total share base.

The representation that the seller does not know any undisclosed material adverse information aligns with Rule 144 requirements and is standard in such notices. Future company filings will provide broader context on ownership changes and any effects from continued stock plan–related sales.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the INSM Form 144 filing disclose about planned share sales?

The Form 144 filing discloses an intent to sell 869 common shares with an aggregate market value of $132,462. The shares are to be sold through Merrill Lynch on NASDAQ, with an approximate sale date of February 5, 2026.

Who is selling INSM shares and how were the shares acquired?

The notice shows sales for the account of Martina Flammer. The 869 shares covered by this Form 144 were acquired on February 1, 2026 via stock plan activity from the issuer, reflecting equity compensation rather than an open-market purchase.

How many INSM shares are outstanding compared with the Form 144 sale?

The filing reports 213,273,469 common shares outstanding. The planned sale of 869 shares under this Form 144 is therefore small relative to the total share base, providing context for the scale of this particular insider-related transaction.

What prior INSM share sales by Martina Flammer are disclosed?

The document lists multiple prior common stock sales by Martina Flammer from November 11, 2025 to February 3, 2026. Individual trades include 31,226 shares on November 11, 2025 and 12,303 shares on January 5, 2026, among other transactions.

On which exchange will the INSM Form 144 shares be sold and through which broker?

The Form 144 states that the 869 common shares are expected to be sold on the NASDAQ market. The broker handling the planned sale is Merrill Lynch, based at 1800 K Street NW, Suite 800, Washington, DC 20006.

What representation does the seller make in the INSM Form 144 filing?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the standard Rule 144 notice and is affirmed by signing the form.
Insmed Inc

NASDAQ:INSM

View INSM Stock Overview

INSM Rankings

INSM Latest News

INSM Latest SEC Filings

INSM Stock Data

31.82B
214.05M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER